Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: The invention relates to an abuse deterrent immediate release tablet.

Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: The present invention provides a high surface area porous carbon material and a process for making this material. In particular, the carbon material is derived from biomass and has large mesopore and micropore surfaces that promote improved adsorption of materials and gas storage capabilities.

Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: Economic conversion of lignocellulose requires both the maximization of conversion of available carbohydrates, as well as minimization of process capital cost. Process intensification minimizes capital cost while preserving conversion yield by combining into a single step those unit operations that are conducted at similar conditions. Flowsheet variations are proposed that minimize process capital while maintaining overall conversion yield.

Abstract: Described are nasal cannulas that improve the precision of the delivered dose for nitric oxide therapy by reducing the dilution of nitric oxide. The nasal cannulas may reduce the total volume and potential for retrograde flow during nitric oxide therapy through the design of the specific dimensions of the flow path and/or having check valves in the nitric oxide delivery line and/or having a flapper or umbrella valve dedicated to nitric oxide delivery. The nasal cannulas may also use materials that limit oxygen diffusion through the cannula walls. The nosepiece for these cannulas may be manufactured by a molding technique.

Abstract: A delivery management system and method enables an individual to create a delivery location and order a product offering from a delivery service provider, and enables the delivery service provider to create a unique delivery schedule by choosing at least one delivery day and time that it will deliver to at least one location, using an interactive communication network.

Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (NO). As described herein, NO dilution can occur because of various factors. To reduce the dilution of an intended NO dose, various exemplary nasal cannulas, pneumatic configurations, methods of manufacturing, and methods of use, etc. are disclosed.

Abstract: The present invention provides a high surface area porous carbon material and a process for making this material. In particular, the carbon material is derived from biomass and has large mesopore and micropore surfaces that promote improved adsorption of materials and gas storage capabilities.

Abstract: The present invention relates to soluble dimeric double metal salt compositions of (?)-hydroxycitric acid (“HCA”), as well as methods for making and using the same. The invention provides dimeric double metal salts of group IA and IIA of HCA (hereinafter, “DDM-HCAs”). The present invention provides methods to make DDM-HCAs of the invention which can be employed to alter the polar/ionic qualities of HCA salts and derivatives to improve solubility of HCA compositions. DDM-HCAs of the invention are soluble HCA-containing compositions useful as dietary supplements and suitable for manipulations under those conditions necessary for tabletting, encapsulation, and the production of dry powders, particularly for use as a beverage premix. Methods of use of the composition include treatment for suppression of appetite, for weight loss, for an increase in the rate of fat metabolism, for reduction in blood lipids and postprandial lipemia, and to increase the plasma level of (?)-hydroxycitric acid.

Abstract: The present invention provides a high surface area porous carbon material and a process for making this material. In particular, the carbon material is derived from biomass and has large mesopore and micropore surfaces that promote improved adsorption of materials and gas storage capabilities.

Abstract: The present invention describes a palatable and orally administrable form of composition comprising proteins, galactomannans and base matrix optionally along with acceptable additives.

Abstract: An intrinsically safe network switch (200) includes five electronically isolated ports, four for connections in hazardous areas (206-1, 206-2, 206-3, 206-4) and one for receiving an unsafe Ethernet input (204). The device may use 10/100 mbps Ethernet cables and connectors and provides speed and activity LED indicators for each port. The device may be din rail-mountable, wall mountable, or desk mountable, and includes an integral heat sink for cool operation. The device incorporates internal barriers and isolated circuitry to guarantee safety and high-integrity signals with resistance to ambient EMI/RFI radiation. This network switch (200) could be any Ethernet communication devices such as hub, managed or unmanaged switch etc. Also, it could have total “n” number of ports (isolated or un-isolated) with 1 port for safe area and “n?1” port of hazardous area. The number of ports for safe and hazardous area can be varied to meet specific application requirements.

Abstract: A method and a system of a chargeback response tool. A chargeback response tool receives chargeback data from a financial vendor and automatically retrieves chargeback dispute evidence relating to the parties involved in the chargeback and about the original transaction from a transaction system that facilitated the original transaction. The chargeback response tool organizes and presents chargeback dispute evidence. The chargeback response tool may also analyze the performance and effectiveness of agents using the tool and of various approaches of disputing chargebacks.

Abstract: The present invention relates to soluble dimeric double metal salt compositions of (?)-hydroxycitric acid (“HCA”), as well as methods for making and using the same. The invention provides dimeric double metal salts of group IA and IIA of HCA (hereinafter, “DDM-HCAs”). The present invention provides methods to make DDM-HCAs of the invention which can be employed to alter the polar/ionic qualities of HCA salts and derivatives to improve solubility of HCA compositions. DDM-HCAs of the invention are soluble HCA-containing compositions useful as dietary supplements and suitable for manipulations under those conditions necessary for tabletting, encapsulation, and the production of dry powders, particularly for use as a beverage premix. Methods of use of the composition include treatment for suppression of appetite, for weight loss, for an increase in the rate of fat metabolism, for reduction in blood lipids and postprandial lipemia, and to increase the plasma level of (?)-hydroxycitric acid.

Abstract: An intrinsically safe network switch (200) includes five electronically isolated ports, four for connections in hazardous areas (206-1, 206-2, 206-3, 206-4) and one for receiving an unsafe Ethernet input (204). The device may use 10/100 mbps Ethernet cables and connectors and provides speed and activity LED indicators for each port. The device may be din rail-mountable, wall mountable, or desk mountable, and includes an integral heat sink for cool operation. The device incorporates internal barriers and isolated circuitry to guarantee safety and high-integrity signals with resistance to ambient EMI/RFI radiation. This network switch (200) could be any Ethernet communication devices such as hub, managed or unmanaged switch etc. Also, it could have total “n” number of ports (isolated or un-isolated) with 1 port for safe area and “n?1” port of hazardous area. The number of ports for safe and hazardous area can be varied to meet specific application requirements.